LifeMD vs Oak: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
Quick Verdict
LifeMD has the higher ClearScore (76 vs 70)
Oak is more affordable ($130/mo vs $199/mo)
LifeMD has higher ratings (4.3/5 vs 4/5)
Oak scores better on value (4.6/5 vs 4.2/5)
LifeMD
$199/mo
starting price
Board-certified doctors prescribing GLP-1s with both compounded and brand-name options. Known for responsive customer service.
Oak
$130/mo
starting price
Affordable compounded GLP-1s. Semaglutide from $130/mo, tirzepatide from $199/mo. No membership fees, free shipping, $50 off first month.
LifeMD vs Oak: Full Comparison
| LifeMD | Oak | |
|---|---|---|
| ClearScore | 76/100 ✓ | 70/100 |
| Overall Rating | 4.3/5 ✓ | 4/5 |
| Review Count | 165 ✓ | 0 |
| Starting Price | $199/mo | $130/mo ✓ |
| Medications | Compounded Semaglutide, Compounded Tirzepatide | Compounded Semaglutide, Compounded Tirzepatide |
| Telehealth | Yes | Yes |
| Insurance | Not accepted | Not accepted |
| HSA/FSA | Accepted | Not accepted |
| Founded | 2020 | 2024 |
| States Served | All 50 states | All 50 states |
Programs & Pricing
LifeMD Programs
GLP-1 Weight Management
$199/mo
Medications: Compounded Semaglutide, Compounded Tirzepatide
- Medication
- Board Certified Doctor
- Ongoing Monitoring
- Free Shipping
Oak Programs
Compounded Semaglutide
From $130/mo
Medications: Compounded Semaglutide
- Medication
- Doctor Consultation
- Care Team Support
- Free Shipping
Compounded Tirzepatide
From $199/mo
Medications: Compounded Tirzepatide
- Medication
- Doctor Consultation
- Care Team Support
- Free Shipping
Ratings Breakdown
| Category | LifeMD | Oak |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
LifeMD edges out Oak with a ClearScore of 76 vs 70. Oak is more affordable starting at $130/mo compared to $199/mo. For customer support, LifeMD rates higher (4.6/5). The best choice depends on your priorities, medication preferences, and budget.